We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Astellas to Expand Oncology Portfolio With Acquisition of OSI
Astellas to Expand Oncology Portfolio With Acquisition of OSI
May 17, 2010
Japanese drugmaker Astellas Pharma has reached a deal to acquire New York-based OSI Pharmaceuticals, ending months of negotiations between the companies and strengthening Astellas’ oncology portfolio.